A Phase II Multicenter Study to Explore the Efficacy and Safety of Brostallicin in Patients With Myxoid Liposarcoma With (12:16) Translocation

Trial Profile

A Phase II Multicenter Study to Explore the Efficacy and Safety of Brostallicin in Patients With Myxoid Liposarcoma With (12:16) Translocation

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2014

At a glance

  • Drugs Brostallicin (Primary)
  • Indications Liposarcoma
  • Focus Therapeutic Use
  • Sponsors Systems Medicine
  • Most Recent Events

    • 03 Mar 2010 Planned end date changed from 1 Apr 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 24 Feb 2009 Fred Oldham added as a lead investigator, as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Checked against clinicaltrials.gov record: added official title and end points.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top